Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
14.88
-0.66 (-4.25%)
Feb 21, 2025, 4:00 PM EST - Market closed
Delcath Systems Employees
Delcath Systems had 76 employees as of December 31, 2023. The number of employees increased by 24 or 46.15% compared to the previous year.
Employees
76
Change (1Y)
24
Growth (1Y)
46.15%
Revenue / Employee
$297,947
Profits / Employee
-$449,000
Market Cap
475.77M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
DCTH News
- 2 days ago - Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call - Business Wire
- 8 days ago - Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma - Business Wire
- 24 days ago - Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Business Wire
- 5 weeks ago - Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 7 weeks ago - Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises - Business Wire
- 2 months ago - Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer - Business Wire
- 3 months ago - Delcath Begins Platform Expansion With Two Phase 2 Trials - Seeking Alpha